News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead (GILD): A Poor Payback Period For Kite Pharma (KITE)?



9/12/2017 6:26:45 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
With an experienced management team and the ability to produce large amounts of free cash flow over time, Gilead Sciences (NASDAQ:GILD) failed for several years to respond to the market sentiment that required the acquisition and development of new businesses. Only now, through the acquisition of Kite Pharma, the company has demonstrated to investors that it can once again be flexible and focus on the development of new products.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES